Cargando…
Emerging cancer therapies and granulocyte-colony stimulating factor in febrile neutropenia patients presenting to the emergency department during the COVID-19 pandemic era
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112942/ https://www.ncbi.nlm.nih.gov/pubmed/37088670 http://dx.doi.org/10.1016/j.ajem.2023.04.021 |
_version_ | 1785027721065136128 |
---|---|
author | Lai, Wei-Jen Hsu, Chen-Xiong |
author_facet | Lai, Wei-Jen Hsu, Chen-Xiong |
author_sort | Lai, Wei-Jen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10112942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101129422023-04-19 Emerging cancer therapies and granulocyte-colony stimulating factor in febrile neutropenia patients presenting to the emergency department during the COVID-19 pandemic era Lai, Wei-Jen Hsu, Chen-Xiong Am J Emerg Med Article Elsevier Inc. 2023-06 2023-04-18 /pmc/articles/PMC10112942/ /pubmed/37088670 http://dx.doi.org/10.1016/j.ajem.2023.04.021 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Lai, Wei-Jen Hsu, Chen-Xiong Emerging cancer therapies and granulocyte-colony stimulating factor in febrile neutropenia patients presenting to the emergency department during the COVID-19 pandemic era |
title | Emerging cancer therapies and granulocyte-colony stimulating factor in febrile neutropenia patients presenting to the emergency department during the COVID-19 pandemic era |
title_full | Emerging cancer therapies and granulocyte-colony stimulating factor in febrile neutropenia patients presenting to the emergency department during the COVID-19 pandemic era |
title_fullStr | Emerging cancer therapies and granulocyte-colony stimulating factor in febrile neutropenia patients presenting to the emergency department during the COVID-19 pandemic era |
title_full_unstemmed | Emerging cancer therapies and granulocyte-colony stimulating factor in febrile neutropenia patients presenting to the emergency department during the COVID-19 pandemic era |
title_short | Emerging cancer therapies and granulocyte-colony stimulating factor in febrile neutropenia patients presenting to the emergency department during the COVID-19 pandemic era |
title_sort | emerging cancer therapies and granulocyte-colony stimulating factor in febrile neutropenia patients presenting to the emergency department during the covid-19 pandemic era |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112942/ https://www.ncbi.nlm.nih.gov/pubmed/37088670 http://dx.doi.org/10.1016/j.ajem.2023.04.021 |
work_keys_str_mv | AT laiweijen emergingcancertherapiesandgranulocytecolonystimulatingfactorinfebrileneutropeniapatientspresentingtotheemergencydepartmentduringthecovid19pandemicera AT hsuchenxiong emergingcancertherapiesandgranulocytecolonystimulatingfactorinfebrileneutropeniapatientspresentingtotheemergencydepartmentduringthecovid19pandemicera |